ZAP70 and B-cell chronic lymphocytic leukemia: 6 These inhibitors were active against both ZAP-70– and ZAP-70+ CLL cells, whereas gefitinib was the only tyrosine kinase inhibitor shown to selectively sensitize ZAP-70+ CLL cells to undergo apoptosis.